- Exchange: NASDAQ GS
- Sector: Consumer, Non-cyclical
- Industry: Healthcare-Products
- Sub-Industry: Patient Monitoring Equip
Snapshot for Insulet Corp (PODD)
| Open: | 18.2300 | Day's Range: | 18.0101 - 18.5800 | Volume: | 625,321 | Bid: | 18.4900 |
|---|---|---|---|---|---|---|---|
| Previous Close: | 18.0000 | 52wk Range: | 14.0000 - 23.3300 | 1-Yr Rtn: | -13.38% | Ask: | 18.5000 |
Key Statistics for PODD
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E (12/2012) | - |
| Earnings Per Share (USD) (ttm) | -1.3200 |
| Est. EPS (USD) (12/2012) | -0.9210 |
| Est. PEG Ratio | - |
| Market Cap (M USD) | 884.29 |
| Shares Outstanding (M) | 47.77 |
| Enterprise Value (M USD) (ttm) | 912.13 |
| Enterprise Value/EBITDA (ttm) | - |
| Price/Book (mrq) | 14.9997 |
| Price/Sale (ttm) | 5.0921 |
| Dividend Indicated Gross Yield | 0.0000 |
| Next Earnings Announcement | 08/02/2012 |
More PODD Key Statistics
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Financials for PODD
- Operating
- Investing
- Financing (M/USD)
Company Profile & Key Executives for PODD
Insulet Corporation is a medical device company that develops, manufactures and markets an insulin infusion system for people with insulin-dependent diabetes.
| Duane M DesistoPresident/CEO | Brian K RobertsChief Financial Officer |
| Charles T Liamos "Charlie"Chief Operating Officer | Peter J DevlinChief Commercial Officer |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Links
Top Forex Trading Resources
Advertisement
Advertisement
Advertisements
Rate this Page